R&D Views & Analysis | pharmaphorum

Views & Analysis

Debates & Insight

Pricing and market access – facts versus fiction

‘Pricing and Market Access Outlook: 2017 Edition’ includes fresh analysis from QuintilesIMS of market forces and pricing policy based on facts and figures behind approvals of new molecular entities in 2015.

Debates & Insight

An integrated digital ecosystem to support patient outcomes,...

Demand for improved pharmaceutical care that enhances the patient experience is ever increasing, and meanwhile outcomes-based medicine has become a key focus for health authorities around the world

White Papers

All change for pharma and biotech partnerships

The pharma industry is always evolving, and in the past decade, there has been an increasing reliance on partnering to strengthen R&D.

Views & Analysis

A history of Johnson & Johnson

Set up by three brothers back in 1886, Johnson & Johnson continues to keep evolving

Pricing and market access – facts versus fiction

An integrated digital ecosystem to support patient outcomes,...

All change for pharma and biotech partnerships

A history of Johnson & Johnson

Hims & Hers buys Australian digital health firm for $1.15bn

How to meet your physicians where they are online

Views & Analysis

Editor's Picks